BANK OF AMERICA CORP /DE/ - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 43 filers reported holding VYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$13,322
-33.4%
88,808
+0.1%
0.00%
Q3 2022$20,000
-41.2%
88,678
+1.4%
0.00%
Q2 2022$34,000
-41.4%
87,428
-2.3%
0.00%
Q1 2022$58,000
-53.6%
89,528
-27.0%
0.00%
Q4 2021$125,000
-18.8%
122,614
+11.2%
0.00%
Q3 2021$154,000
-70.6%
110,274
-26.1%
0.00%
Q2 2021$524,000
-36.3%
149,218
+24.2%
0.00%
Q1 2021$822,000120,1420.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,551,000$2,602,0002.01%
Perceptive Advisors 4,356,044$4,444,0000.03%
GSA CAPITAL PARTNERS LLP 217,747$222,0000.03%
Virtu Financial LLC 175,278$179,0000.02%
XTX Topco Ltd 17,053$17,0000.01%
SkyOak Wealth, LLC 27,200$28,0000.01%
DELTEC ASSET MANAGEMENT LLC 30,000$31,0000.01%
Tekla Capital Management LLC 135,395$138,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$64,0000.00%
TWO SIGMA SECURITIES, LLC 47,475$48,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders